These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 8588864

  • 1. Structure-activity relationships of synthetic cardiac glycosides.
    Takechi M, Uno C, Tanaka Y.
    Phytochemistry; 1996 Jan; 41(1):125-7. PubMed ID: 8588864
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Structure-activity relationships of saponins and cardiac glycosides. III. Beta-L-xylopyranosyl-(1-->6)-alpha- and -beta-D-glucopyranosides.
    Takechi M, Uno C, Tanaka Y.
    Biol Pharm Bull; 1998 Nov; 21(11):1234-5. PubMed ID: 9853422
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Biological activities of synthetic triterpenoid and steroid beta-D-glucopyranosyl-(1-->2)-alpha-D-glucopyranosides.
    Takechi M, Kousaka Y, Uno C, Tanaka Y.
    Planta Med; 1998 Mar; 64(2):179-80. PubMed ID: 9525112
    [Abstract] [Full Text] [Related]

  • 6. Prospects and Therapeutic Applications of Cardiac Glycosides in Cancer Remediation.
    Ayogu JI, Odoh AS.
    ACS Comb Sci; 2020 Nov 09; 22(11):543-553. PubMed ID: 32786321
    [Abstract] [Full Text] [Related]

  • 7. Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization.
    Langenhan JM, Peters NR, Guzei IA, Hoffmann FM, Thorson JS.
    Proc Natl Acad Sci U S A; 2005 Aug 30; 102(35):12305-10. PubMed ID: 16105948
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The cytotoxic activities of cardiac glycosides from Streptocaulon juventas and the structure-activity relationships.
    Xue R, Han N, Ye C, Wang L, Yang J, Wang Y, Yin J.
    Fitoterapia; 2014 Oct 30; 98():228-33. PubMed ID: 25128424
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Modulators of Na/K-ATPase: a patent review.
    Wang HY, O'Doherty GA.
    Expert Opin Ther Pat; 2012 Jun 30; 22(6):587-605. PubMed ID: 22595010
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis of Acovenosides: Cardiac Glycosides with Potent Antitumor Activities.
    Liu B, Bi S, Wang J, Xu P, Yu B.
    Org Lett; 2024 Oct 18; 26(41):8725-8729. PubMed ID: 39420814
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and identification of cytotoxic diphyllin glycosides as vacuolar H(+)-ATPase inhibitors.
    Zhang Z, Ma J, Zhu L, Zhao Y.
    Eur J Med Chem; 2014 Jul 23; 82():466-71. PubMed ID: 24929344
    [Abstract] [Full Text] [Related]

  • 16. The Antiviral Effects of Na,K-ATPase Inhibition: A Minireview.
    Amarelle L, Lecuona E.
    Int J Mol Sci; 2018 Jul 24; 19(8):. PubMed ID: 30042322
    [Abstract] [Full Text] [Related]

  • 17. New advances in synthesis and clinical aspects of pyrazolo[3,4-d]pyrimidine scaffolds.
    Abdellatif KRA, Bakr RB.
    Bioorg Chem; 2018 Aug 24; 78():341-357. PubMed ID: 29627655
    [Abstract] [Full Text] [Related]

  • 18. Cardiac glycosides in cancer research and cancer therapy.
    Winnicka K, Bielawski K, Bielawska A.
    Acta Pol Pharm; 2006 Aug 24; 63(2):109-15. PubMed ID: 17514873
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Na+,K(+)-ATPase inhibiting activity of cardiac glycosides from Erysimum cheiranthoides.
    Lei ZH, Kuniyasu A, Tai BS, Nakayama H, Nohara T.
    Planta Med; 2001 Jun 24; 67(4):369-70. PubMed ID: 11458460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.